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ABSTRACT
Nucleic acids are important bio-macromolecules in living systems. They are involved in
important functions like gene expression and regulation. Nucleoside triphosphates serve as
precursors for biochemical synthesis of modified nucleic acids and nucleotide coenzymes. The
modification of nucleic acids, particularly at nucleobases, can expand the function and chemical
properties of nucleic acid. Herein, we report the chemical synthesis of a novel thiol-modified
nucleoside

S-(3-(acetylthio)propyl)-5-(mercaptomethyl)-uridine

and

the

corresponding

nucleotide via a “new synthetic methodology” developed in our laboratory. The synthesized
triphosphate was used for RNA transcription. The activity and nuclease resistance of the
transcribed RNA is studied. The results showed that the properties of the nucleotide with thiol
functionality are as good as the native. The modified RNA can be used for RNA/protein

complex structure studies and gold nanoparticles stabilizer. They can also serve as a probe in
DNA/RNA microchip surface functionalization for detection of various diseases and pathogens.
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1
1.1

INTRODUCTION

Nucleic acids
Nucleic acids, which include deoxyribonucleic acids (DNA) and ribonucleic acid (RNA),

are important bio-macromolecules with polymeric structure in living systems. They are essential
for all known forms of life. Because of the specific structure of nucleic acids and their crucial
role in genetic systems, fully understanding the chemistry of DNA and RNA constitutes a central
element in our knowledge of any kind of life existing in the universe. The quest for such an
understanding has been an initiation of many research areas in the nucleic acid field. For
example, synthesis of chemically modified nucleic acid analogous and comparing them with the
natural counterparts has been one of the most interesting strategy to investigate properties of
nucleic acids.2,3 Nowadays, more and more attention has been put on the synthesis and
modification of nucleic acid derivatives.4-7 Various modifications in nucleic acid structure have
helped scientists to have an in-depth understanding about nucleic acid structures and functions.8,9
Nucleoside triphosphates, which are the building block of nucleic acids, serve as direct
precursors for chemical synthesis of modified unnatural nucleic acids and nucleotide
coenzymes.10,11 Over the past few decades, nucleoside triphosphates (NTPs) and deoxynucleoside triphosphates (dNTPs) are finding widespread application in biochemistry and
molecular biology as substrates for DNA and RNA polymerases for sequencing, mutagenesis,
and the labeling of hybridization probes and also therapeutics.12-15 The emergence of RNA/DNA
technology and unusual properties of DNA/RNA molecules has drawn the attention of
researchers in RNA chemistry, biochemistry and molecular biology.16

2

1.2

Thiol modified nucleosides and nucleotides
Medicinal problems have been concern for all societies. Nano-science is one of the most

progressing areas in today’s research; therefore, it should be beneficial for human health and
curing disease. Metal nanoparticles started having therapeutic application in 1970s. Among all
metals, gold nanoparticles (AuNPs) have been proved to be superior to classic compounds.17
There are many methods to prepare and stabilize medically useful AuNPs. Various
stabilizers can be utilized to keep high quality of AuNPs such as: citrate, various ligands,
polymers, dendrimers, surfactants and also biomolecules such as oligonucleotides and DNA and
RNA. Thiolates (for instance oligonucleotides modified with a thiolate group) have been proved
to be the best stabilizer for AuNPs.17-19 This is based on the fact that thiol functionality has a
strong tendency to form self-assembled monolayers in gold surface by being chemisorbed. DNA
and RNA can immobilize AuNPs if they are modified by thiol functionalities. Thiols can
stabilize AuNPs by forming a strong Au—S bond between the soft “Au” acid and the soft base
“S”.20
Herein, we report the synthesis of a novel thiol modified nucleoside and corresponding
nucleotide and biochemical studies of the thiol-RNA/DNA. Our ultimate goal is to use this thiolfunctionalized triphosphate and DNA/RNA to stabilize AuNPs. Our hypothesis is that
incorporating multiple thiol functionality into the oligonucleotide could increase the stability of
the S—Au bond; therefore, more stabilized AuNPs. These stabilized AuNPs will be further used
in DNA/RNA microchip surface functionalization for detection of various diseases and
pathogens. Moreover, the thiol-oligonucleotide thus formed can also serve as a probe for
RNA/protein complex structure and functions studies.

3

2

EXPERIMENTAL

S-(3'-S-acetylpropyl)-5-(mercaptomethyl)-uridine was synthesized from 5-methyl uridine in
seven steps. The purified nucleoside then was used to synthesize S-(3'-S-acetylpropyl)-5(mercaptomethyl)-uridine -5'-triphosphate. The triphosphate thus formed was used as a substrate
for T7 RNA polymerases. The stability of the transcribed thiol-RNA was tested by treating with
different nuclease enzyme to investigate its resistance. The activity of the hammerhead
ribozyme, product of the transcription, was tested as well. The 2’-deoxy version of this
nucleotide was synthesized previously by us using similar procedure and it is reported as a part
of dissertation of our former lab member1. Herein, I am reporting again some of our result from
2’-deoxy version for the comparison purposes.
2.1

Materials and instrumentation
Most solvents and reagents were purchased from Sigma-Aldrich, Fisher Scientific and

Fluka and were used as obtained, unless otherwise specified. Solid reagents were dried under
high vacuum. The reactions were performed under argon gas with stirring. All solvents were
dried and purged with argon before use. Solvent mixtures are indicated as volume/volume ratios.
Analytical thin layer chromatography (TLC, Dynamic Adsorbents, Inc.) was conducted using
alumina basic TLC plates with F254 indicator (0.250 mm thick), and visualized under UV-light.
Column chromatography was performed using Fluka silica gel (mesh size 0.040 – 0.063 mm).
Transcription experiment was done using T7 RNA Polymerase and Transcription Kit from
Epicenter Company. A DNA template (55 nt, 5’-TGTACGTTTCGGCCTTTCGGCCTCATCAG
GTTGCCATAGTGAGTCGTATTACGC-3’) was designed and synthesized on solid phase for
in vitro transcription of the thiol-modified hammerhead ribozymes using the NTPs analogues. T7
RNA

polymerase

promoter

(top

strand

DNA,

55-nt, 5’-GCGTAATACGACTCACT

4

ATAGGCAACCTGATGAGGCCGAAAGGCCGAAACGTACA-3’) and an RNA substrate (5’GGUCAUCUUUCCUAC-CUGUACGUCGUUGCCUAA-3’) for activity study were purchased
from Integrated DNA Technologies. RNase R was bought form Epicenter. Phosphodiesterase I
from Crotalus Adamanteus venom and Fetal Bovine Serum (FBS) were purchased from SigmaAldrich and Life Technologies respectively. The DNA templates and primer used for enzymatic
incorporation of the 2’-deoxy nucleotide was synthesized by solid phase synthesis.
NMR spectra were recorded on Bruker-400 MHz. All chemical shifts (δ) are in ppm
relative to tetramethylsilane (TMS). High-resolution mass spectra (HR-MS) and MALDI
analyses were performed at Georgia State University Mass Spectrometry Facility, Atlanta,
Georgia.

2.2

Synthesis of the thiol-functionalized nucleoside
S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine was synthesized from 5-methyl uridine

in seven steps (Scheme 2.1). The 2’-deoxy version was also synthesized using similar
methodology. Herein, the focus of synthesis report is on the ribo version of the nucleoside.

5

Scheme 2.1 Synthesis of S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine, (7); The pink color
shows the substituent atoms for the 2’-deoxy version of the nucleosides.

2.2.1

2', 5'-Bis-O-(tert-butyldimethylsilyl)-5-methyluridine, 1

5-methyl uridine (1 g, 0.0039 mol), tert-butyldimethylsilyl chloride (TBDMSi-Cl) (3.5 g,
0.0192 mol, 6 eq) and imidazole (1.6 g, 0.0192 mol, 6 eq) were dissolved in anhydrous
dimethylformamide (DMF) (10 mL). The reaction mixture was stirred for 12 h at room
temperature. The reaction progress was monitored by recording TLC (5% ethyl acetate in
dichloromethane; Rf = 0.4). When starting material was consumed completely, the reaction
mixture was poured into ethyl acetate (150 mL) and extracted with saturated sodium bicarbonate

6

solution (8 X 50 mL). The organic phase was dried over anhydrous magnesium sulfate (MgSO4).
The solvent was evaporated under reduced pressure. The pale yellow oily syrup was purified via
silica gel flash column chromatography (2% methanol in dichloromethane) to give compound 1
(3.2 g, 100% yield) as a colorless sticky liquid. HR-MS (ESI): chemical formula: C22H42N2O6Si2,
Observed mass [M-H]-: 485.2499 (Calculated mass = 485.2509): Figure 3.1Error! Reference
ource not found.; 1H NMR (CDCl3): Figure 3.2; 13C NMR (CDCl3): Figure 3.3
2.2.2

2', 5'-Bis-O-(tert-butyldimethylsilyl)-5-bromomethyl-uridine, 2

2', 5'-Bis-O-(tert-butyldimethylsilyl)-uridine, 1 (800 mg, 1.64 mmol), N-bromosuccinimide (730 mg, 4.1 mmol, 2.5 eq.), and benzoyl peroxide (32 mg, 0.1312 mmol, 0.08 eq.)
were dissolved in CCl4 (25 mL). The reaction was heated to reflux for 1 h, during this time the
solution changed from colorless to orange. Completion of the reaction was monitor by TLC,
using 8% ethyl acetate in dichloromethane as eluent (Rf = 0.6). The reaction was allowed to cool
and filtered to remove insoluble succinimide. The solvent was evaporated in vacuo to yield a
crude yellow 2', 5'-bis-O-(tert-butyldimethylsilyl)-5-bromomethyl-uridine, 2. The crude
compound 2 was used as such, without further purification for the next step.
2.2.3

S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 3

Crude compound 2 and potassium thioacetate (AcSK) (470 mg, 4.1 mmol, 2.5 eq. of
compound 1) were placed in a 50 mL flask and dried under vacuum for about 30 minutes.
Anhydrous DMF (3 mL) was added to the reaction flask, under argon atmosphere. The reaction
was heated at 70 °C for 1.5 h. The reaction mixture was diluted with ethyl acetate (90 mL) and
washed with saturates NaHCO3 aqueous solution (5 X 30 mL).The organic phase was dried
using anhydrous MgSO4. The solvent was evaporated in vacuo to yield dark brown oily syrup of
crude compound 3. The crude product 3 was purified using gradient column chromatography (0,

7

1, 2, 3% EtOAc in CH2Cl2) to yield a brown product. Rf = 0.4 in 8% ethylacetate in CH2Cl2; HRMS (Figure 3.4): Chemical formula: C24H44N2O7SSi2, Observed mass [M-H]-: 559.2339
(Calculated mass = 559.2330), 1H NMR (CDCl3) (Figure 3.5) and

13

C NMR (CDCl3) (Figure

3.6).
2.2.4

2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 4

Compound 3 was dissolved in MeOH (3 mL) and hydrolyzed using 1 M NaOH/MeOH
solution (1 mL). Based on TLC (using 8% ethyl acetate in CH2Cl2, Rf = 0.2) the reaction
completed in 4 h at room temperature. The reaction mixture was neutralized with AcOH and
solvent was evaporated under reduced pressure to yield dark brown solid. The crude compound 4
was used as such for the next step.
2.2.5

S-(3-bromopropyl)-2',5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)uridine, 5

Crude compound 4, K2CO3 (2 eq.) and DTT (1 eq.) were placed in a 50 mL flask and dried
under vacuum for about 15 min. Anhydrous DMF (5 mL) was added to the reaction flask, under
argon atmosphere. The reaction was stirred at room temperature for 1 h. Reaction progress was
monitored by TLC (5 % EtOAc in CH2Cl2, Rf = 0.2). 1,3-Dibromopropane (10 eq.) was added
drop wise to the reaction mixture, under argon atmosphere, with vigorous stirring. The reaction
was stirred at room temperature for 12 h. The reaction mixture was diluted with ethyl acetate (60
mL) and washed with saturated aqueous NaHCO3 solution (20 mL, five times).The organic
phase was dried using anhydrous MgSO4. The solvent was evaporated in a reduced pressure
rotary evaporator to yield brown oily compound 5. The crude product 5 was purified using
gradient column chromatography (0, 1, 2, 3% EtOAc in CH2Cl2) to yield a golden-brown oily
product. Rf = 0.45 in 5% EtOAc in CH2Cl2; HR-MS (Figure 3.7): Chemical formula:

8

C25H47BrN2O6SSi2, Observed mass [M-H]-: 637.1819 (Calculated mass = 637.1877), 1H NMR
(CDCl3) (Figure 3.8) and 13C NMR (CDCl3) (Figure 3.9).
2.2.6

S-(3(acetylthio)propyl)-3',5'-bis-O-(tert-butyldimethylsilyl)-5-mercaptomethyl)uridine, 6

Compound 5 and AcSK (2.5 eq.) were placed in a 50 mL flask and dried under vacuum
for about 15 min. Anhydrous DMF (5 mL) was added to the reaction flask, under argon
atmosphere. The reaction was heated at 70 °C for 1.5 h. The reaction mixture was diluted with
ethyl acetate (60 mL) and washed with saturated NaHCO3 solution (5 X 20 mL).The organic
phase was dried using MgSO4. The solvent was evaporated in vacuo to yield brown oily
compound 6. The crude product 6 was purified using gradient column chromatography (0, 1, 2, 3
and 4% EtOAc in CH2Cl2) to yield a golden brown oily product. Rf = 0.5 in 8% ethylacetate in
CH2Cl2; HR-MS (Figure 3.10): Chemical formula: C27H50N2O7S2Si2 Observed mass [M-H]-:
633.2547 (Calculated mass = 633.2525); 1H NMR (CDCl3) (Figure 3.11) and 13C NMR (CDCl3)
(Figure 3.12).
2.2.7

S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine, 7

Compound 6 (30 mg, 0.047 mmol) was dissolved in dry tetrahydrofuran (1 mL).
Triethylamine-trihydrofluoride (20 μL, 0.47 mmol. 10 eq.) was added to the reaction flask, under
argon atmosphere, while stirring. The reaction was heated at 45 °C for 12 h. Reaction progress
was monitored by analytical TLC (eluent: 10% MeOH in CH2Cl2). The reaction mixture was
neutralized by triethylamine. The solvent was evaporated under reduced pressure and the crude
product 7 was purified using preparative TLC plate (10% MeOH in CH2Cl2, Rf = 0.5) to yield 7
(2 mg, 10%) as a pale orange solid product. HR-MS (Figure 3.13): Chemical formula:
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C15H22N2O7S2, Observed mass [M-H]-: 405.0787

(Calculated mass = 405.0868); 1H NMR

(MeOD) (Figure 3.14) and 13C NMR (MeOD) (Figure 3.15).
2.3

Synthesis of the thiol-functionalized nucleoside-5’ triphosphate
2.3.1

S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridin-5’ triphosphate, 9

S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine ([compound 7, Scheme 2.1],10 mg,
0.015 mmol) was weighed in a 10 mL round bottom flask and dried overnight under vacuum. 2chloro-4H-1,3,2-benzodioxaphosphorin-4-one (5 mg, 1.5 eq.) was dried in another flask for 5
minutes. Tributylammonium pyrophosphate (25 mg, 3 eq.) was dried overnight in a separate
flask, under high vacuum. The 2-chloro-4H-1,3,2-benzodioxa-phosphorin-4-one was dissolved in
dry DMF (0.1 mL) . The pyrophosphate was also dissolved in dry DMF (0.3 mL) with additional
tributylamine (TBA) (0.1 mL) and transferred by a syringe into the flask containing the 2-chloro4H-1,3,2-benzodioxa-phosphorin-4-one under argon atmosphere. A lot of argon was purged
through the reaction flask as the mixture was allowed to react at room temperature. The mixture
was allowed to stir at room temperature for 45 minutes to yield an inorganic triphosphate. During
that time, the vacuum dried compound 7 was dissolve in dry DMF (0.3 mL) and an additional of
dry toluene (0.1 mL). The prepared triphosphate solution was added to the flask containing
compound 7. The combined contents were allowed to stir at room temperature for 2.5 h to yield
the cyclic phosphite intermediate 8 (Scheme 2.2). Reaction was monitored at this step by TLC
(10% MeOH in CH2Cl2; Rf = 0.35). The cyclic-phosphite 8 was then oxidized by adding iodine
solution (0.1% I2/THF/Pyridine/H2O, 0.4 mL). The mixture was stirred for 40 min and then
hydrolyzed with water (3 mL) and allowed to stir at room temperature for 12 h to ensure
complete hydrolysis. The sample was precipitated using NaCl (0.3 M)/ ethanol (3 volumes). The
precipitate was analyzed using analytical TLC (5:3:2 of iso-PrOH:30% NH3.H2O:H2O; Rf = 0.3).
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The crude S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5'-triphosphate was desalted by a
syringe filter to be prepared for HPLC purification. The sample was then purified and analyzed
by reversed-phase high performance liquid chromatography (RP-HPLC). 5% yield; HR-MS
(Figure 3.16): Chemical formula:

C15H25N2O16P3S2, Observed mass [M-H]-: 644.9756

(Calculated mass = 644.9786); 1H NMR (D2O) (Figure 3.17); 13C NMR (D2O) (Figure 3.18); 31P
NMR (D2O) (Figure 3.19).
2.3.2

S-mercaptopropyl-5-(mercaptomethyl)-uridin-5’ triphosphate, 10

The pure triphosphate 9 was treated with ammonia in 5% ammonium hydroxide in
methanol/water 1:1 (v/v) solution at room temperature and overnight to remove acetyl group
from the thiol functionality in the side chain. Then ammonia was evaporated in vacuu-fuge. The
pH of the sample was checked to make sure it is neutral. Then, it was precipitated in NaCl (0.3
M)/ ethanol (3 volumes). HR-MS (Figure 3.20): Chemical formula: C15H25N2O16P3S2, Observed
mass [M-H]-: 644.9756 (Calculated mass = 644.9786); 1H NMR (D2O) (Figure 3.21); 13C NMR
(D2O) (Figure 3.22); 31P NMR (D2O) (Figure 3.23).
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Scheme 2.2 Synthesis of S-mercaptopropyl-5-(mercaptomethyl)-uridine-5'-triphosphate (The
pink color indicates the 2’-deoxy version)

2.4

RP-HPLC Analysis and Purification
The crude compound 9 (AcSUTP) was purified and analyzed by reverse-phase high-

performance liquid chromatography (RP-HPLC). The purification was performed on a
Welchrom C18-XB (10 μm, 21.1 × 250 mm) preparative column, using Shimadzu SPD-10A VP
liquid chromatography by monitoring under 260 nm, with a flow-rate of 6 mL/min [buffer A: 10
mM triethylammoniumacetate (TEA.Ac, pH 7.1) in water; buffer B: 10 mM TEA.Ac (pH 7.1) in
50% acetonitrile in water] and a linear gradient starting from 5% buffer B to 40% buffer B in 10
min, reaching 100% buffer B in 20 min and in 30 min going back to 5% buffer B. The desired
peak was collected and the buffer was removed by lyophilization. All the dry fractions of
compound 9 were analyzed on Welchrom C18-XB column (4.6 × 250 mm, 5 μ) and measured at
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a flow rate of 1.0 mL/min and a linear gradient of 0 to 25% buffer B in 20 min, reaching to 100%
buffer B in 22 min, staying at 100% buffer B for 5 minutes, then going back to 0% buffer B till
the end of program, which was totally 36 min [buffer A: 20 mM TEA.Ac (pH 7.3) in water;
buffer B: 20 mM TEA.Ac (pH 7.3) in 50% acetonitrile]. A RP-HPLC profile of crude compound
9 is shown in Figure 3.24. And RP-HPLC analysis of purified compound 9, at 260 nm
wavelength, is presented in Figure 3.25. The white precipitates of compound 10 (HSUTP) were
also analyzed by analytical RP-HPLC at 260 nm with a flow rate of 1.0 mL/min and a linear
gradient of 0 to 25 % buffer B in 20 min (Figure 3.25).
2.5

UV-VIS property study
UV-VIS spectra were obtained by a reference to deionized water (Figures 3.27 and 3.28).

The base line was subtracted from the recorded spectra all the time.
2.6

Synthesis of oligonucleotides
The DNA primer (P) and template (T) sequences (Table 3.1) were synthesized by solid

phase synthesis on an automated Applied BioSystem 394 DNA Synthesizer (Applied
Biosystems, Foster City, CA) using standard β-cyanoethylphosphoramidite chemistry (1 μmol
scale).1 Oligonucleotides were synthesized in DMTr-off mode, with average coupling efficiency
more than 99%. The oligonucleotides were de-protected in concentrated NH4OH (55 °C, 16 h),
and purified by 19% denaturing polyacrylamide gel electrophoresis. The gel was visualized
under UV light. The desired band was cut off and transferred into a tube, crushed and soaked in
water overnight. Water was removed by lyophilization and the residue of the gel was soaked
again in order to maximize the extraction of oligonucleotide from the gel. The oligonucleotides
were dissolved in less amount of water and then recovered from water solution by NaCl (0.3 M)/
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ethanol (3 volumes) precipitation. Oligonucleotides were quantified by UV-Vis absorbance at
260 nm using standard molar extinction coefficients and characterized by MALDI-TOF MS.1
2.7

Enzymatic studies
2.7.1

RNA transcription

Transcription experiment was performed by following the standard procedures from the
manufacturer, Epicentre (AmpliScribe T7- Flash Transcription Kit).21 The materials for the
transcription experiments were labeled using radioactive ATP Alpha 32P (Perkin Elmer, Boston,
MA). Each transcription reaction (5 μL) contained ATP, CTP, GTP, and UTP or HSUTP or
AcSUTP (0.5 mM each), linearized plasmid DNA template (1 μM) (T55: 5′-TGT ACG TTT
CGG CCT TTC GGC CTC ATC AGG TTG CCT ATA GTG AGT CGT ATT ACG C-3’), the
complementary 55-nt promoter, DTT (10 mM), transcription buffer (1×) for T7 RNA
polymerase, T7 RNA polymerase (1 unit/μl), and RNase-free water. In order to minimize
pipetting error, all the materials except the T7 RNA polymerase enzyme and uridine
triohosphates (UTP, HSUTP and AcSUTP) were mixed together in a cocktail solution, then
divided into three portions to be used for the three different substrates. The T7 RNA polymerase
enzyme was added the last to each reaction vial. In the time-course experiments, a gel-loading
dye (10 μl) saturated with urea and containing 100 mM EDTA was used to quench the reaction at
each time point, then the reaction mixture was stored in dry ice until the end of experiment. It
was followed by loading 5 μl of the reaction mixture containing dye on a 19% denaturing
polyacrylamide gel electrophoresis and then autoradiography (Figure 3.29). The transcription
experiment was further performed using three more different templates (Figure 3.30):
T G4 :

5’- TGT GCG TTT CGG CCT TTC GGC CTC ATC AGG TTG CCT ATA GTG AGT

CGT ATT ACG C-3’
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T G28 : 5’- TGT ACG TTT CGG CCT TTC GGC CTC GTC AGG TTG CCT ATA GTG AGT
CGT ATT ACG C-3’
T G32 : 5’- TGT ACG TTT CGG CCT TTC GGC CTC ATC GGG TTG CCT ATA GTG AGT
CGT ATT ACG C-3’
2.7.2

Ribozyme activity study

Transcription of the hammerhead ribozyme (5′-GGCAACCUGAUGAGGCCGAAAGG
CCGAAACGUACA-3’) for the catalytic activity experiments was carried out using the standard
procedures described previously (150 μL reaction scale). For this transcription experiment, the
55-nt double stranded DNA (5′-TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTAT
AGTGAGTCGTATTACGC-3′) and its complementary sequence was used. After the
transcription, the native and thiol-modified ribozymes were precipitated in NaCl (0.3 M)/ ethanol
(3 volumes) and adjusted to the same concentration, monitored by UV-VIS and using standard
extinction coefficient for oligonucleotides. The RNA substrate (20 nt, 5′-ACCUGUACGUCG
UUGCCUAA-3′; Integrated DNA Technology (IDT), Coralville, IA) was kinased with γ-32PATP at the 5′ end for the ribozyme digestion by one hour incubating the RNA with T4
polynucleotide kinase (Thermo Fisher Scientific, Waltham, MA) and 1x reaction buffer for T4
PNK at 37 °C , followed by NaCl (0.3 M)/ ethanol (3 volumes) precipitation. The digestion was
completed in the buffer (10 mM Tris-HCl, 10 mM MgCl2, pH 7.6) and with 5′-32P-labeled RNA
substrate (final concentration: 50 μM) at room temperature. Aliquots (5 μL each) were taken at
the time intervals (0, 5, 10, 30, 60, and 120 min), and each was diluted with 10 μL gel loading
dye containing EDTA (50 mM) and saturated urea solution (aqueous), followed by storing in dry
ice to quench the digestion. The 5′-radio labeled RNA substrate was cleaved into the 9-nt
fragment and the 5′-32P-RNA fragment (11-nt). Digestion of the

32

P-labled RNA substrate was
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monitored via denaturing 19% polyacrylamide gel electrophoresis and autoradiography. The
time-course results of the ribozyme digestion are shown in Figure 3.31.
2.7.3

Ribozyme durability study

The procedure of durability study was the same as that of ribozyme activity study
mentioned above. However, the concentration of the transcribed ribozyme was diluted to 1:10 of
that in activity study. Moreover, the time intervals were as: 0, 2, 4, 6, 24 and 72 h. The 19%
denaturing polyacrylamide gel electrophoresis of this study was then visualized by
autoradiography (Figure 3.32).
2.7.4

Nuclease resistance experiment

The ribozymes were transcribed as previously discussed. The transcribed ribozymes were
purified by centrifugation using a membrane (3000 Dalton cutoff). The concentrated samples
were adjusted to the same molar concentration, analyzed by UV-VIS. These modified and native
ribozymes were then digested with fetal bovine serum (FBS), RNase R and phosphodiesterase I
from Crotalus Adamanteus venom. The digestion time was set for 30 min, 1 and 2 h at 37°C. In
order to find the best resistance of the synthesized ribozymes, different concentration of the
nuclease enzymes were used. The reaction was quenched by adding 7 μL of gel loading dye
containing EDTA (100mM), saturated with urea. The digestion reactions were analyzed by 19%
PAGE and autoradiography (Figures 3.33, 3.34, 3.35 and 3.36).
2.7.5

DNA polymerization of the 2’-deoxy version nucleotide1

The 5’-end of the DNA primers were radio-labeled using γ-[32P]-ATP (Perkin Elmer,
Boston, MA) and T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and incubating
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at 37 °C for one hour. The kinase reaction was quenched by heating up the reaction mixture to 70
°C for five minutes, followed by NaCl (0.3 M)/ ethanol (3 volumes) precipitation.
DNA primer(s) (P1 or P2, Table 3.1) and DNA template(s) (T1, T2 or T3, Table 3.1),
dNTPs (dATP, dCTP and dGTP, Epicentre Biotechnologies, Madison, WI), dNTP substrate
(TTP/ AcSTTP/ HSTTP) and DTT were premixed together in Klenow exo-minus DNA
polymerase

10x

reaction

buffer.

Klenow

exo-minus

DNA

polymerase

(Epicentre

Biotechnologies, Madison, WI) was added to the prepared cocktail solution and incubated at 37
°C for the desired time. The reaction mixtures were quenched by adding the gel loading dye
solution (10 μL each, containing 50 % glycerol, 0.60 % xylene cyanol, 0.60 % bromophenol
blue, 20 mL of 1 mM EDTA, saturated urea) and analyzed on 19%, polyacrylamide gel
electrophoresis (PAGE). For single nucleotide enzymatic incorporation reactions, no other
dNTPs, except the T substrate (TTP/ AcSTTP/ HSTTP), were added to the reaction mixture. The
reaction mixtures were incubated at 37 °C for desired time. Analysis was done on a 19%,
polyacrylamide gel electrophoresis. Polymerase reactions contained primer (1.5 μM), template (3
μM), dNTPs (0.1 mM each), DTT (5 mM), and 10X reaction buffer (1X) in a final reaction
volume of 5 μL.
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3
3.1

RESULTS AND DISCUSSION

Synthetic route design and characterization of the synthesized compounds
As shown in Scheme 2.1, both S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine and S-

(3’-S-acetylpropyl)-5-(mercaptomethyl)-2'-deoxyuridine were synthesized similarly from 5methyluridine and thymidine, respectively, in seven steps. Compounds 1, 2 and 3 were
synthesized based on literature reported methodology.15 The nucleoside 5’-triphosphates were
synthesized using new methodology developed in our lab22 (Scheme 2.2) and then characterized
successfully.
The free 2'- and 5'- hydroxyl groups on 5-methyluridine, as well as the 3’ and 5’ –OH
groups on thymidine were protected with tert-butyldimethylsilyl protecting group. The reaction
was quite clean and efficient yielding nearly 100% of pure 2', 5'-bis-O-(tert-butyldimethylsilyl)5-methyluridine and 3', 5'-bis-O-(tert-butyldimethylsilyl)-thymidine. Formation of compound 1
was confirmed by high resolution mass spectrometry (Figure 3.1), and the purity of the
compound was analyzed by 1H (Figure 3.2) and 13C NMR (Figure 3.3).

Figure 3.1 ESI-MS analysis of 2', 5'-Bis-O-(tert-butyldimethylsilyl)-uridine, 1, Chemical
formula: C22H42N2O6Si2, Observed mass [M-H]-: 485.2499 (Calculated mass = 485.2509)
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Figure 3.2 1H NMR of 2', 5'-bis-O-(tert -butyldimethylsilyl)-5-methyluridine, 1.

Figure 3.3 13C NMR of 2', 5'-bis-O-(tert -butyldimethylsilyl)-5-methyuridine, 1.
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3', 5'-bis-O-(tert-butyldimethylsilyl)-5- bromomethyl-uridine (2) was yielded by using Nbromosuccinimide to afford radical bromination at benzylic position under reflux conditions, in
the presence of catalytic amounts of benzoyl peroxide. Using filtration, residual insoluble
succinimide was then removed. Compound 2 was used instantly without any purification. Since
this compound was difficult to purify, any characterization of it was difficult.
Nucleophilic substitution of bromide in compound 2 was accomplished by using
thioacetate to obtain S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine
(compound 3). The molecular formation of compound 3 was confirmed by ESI-MS (high
resolution) analysis (Figure 3.4). The purity of compound 3 was confirmed by NMR analysis
(Figures 3.5 and 3.6).
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Figure 3.4 ESI-MS analysis of S-acetyl-2',5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)uridine, 3 , Chemical formula: C24H44N2O7SSi2. Observed mass [M-H] : 559.2339

(Calculated mass = 559.2330)
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Figure 3.6 1H NMR of S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)uridine, 3.

Figure 3.5 13C NMR of S-acetyl-3', 5'-bis-O-(tert-butyldimethylsilyl)-5(mercaptomethyl)-2'-deoxyuridine, 3.
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Compound 4 was afforded by alkaline hydrolysis of compound 3 using sodium hydroxide
in methanol. Due to strong tendency of un-protected S-H group on compound 4 to form a dimer
by making disulfide bond, any characterization or purification of it was difficult. Therefore, the
sample was used as such for the next step.
The disulfide bind thus formed resulting from dimerization of compound 4 was reduced
in situ with dithiothreitol (DTT). The reaction was done in an argon rich, oxygen free
atmosphere. The free thiol anion [ –S]- thus generated, was alkylated using 1,3-dibromopropane
to afford compound 5. Compound 5 is a stable intermediate and was purified by column
chromatography and characterized by NMR (Figures 3.8 and 3.9). The molecular formation of
compound 5 was confirmed by ESI-MS (high resolution) analysis (Figure 3.7).
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Figure 3.7 ESI-MS analysis of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5(mercaptomethyl)-uridine, 5, Chemical formula: C25H47BrN2O6SSi2 , Observed mass [MH]-: 637.1819 (Calculated mass = 637.1877).
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Figure 3.8 1H NMR of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5(mercaptomethyl)-uridine, 5

Figure 3.9 13C NMR of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5(mercaptomethyl)-uridine, 5
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Nucleophilic substitution of bromide in compound 5 by thioacetate yielded compound 6.
The molecular formation of compound 6 was confirmed by ESI-MS (high resolution) analysis
(Figure 3.10). The purity of compound 6 was analyzed by NMR (Figures 3.11 and 3.12).
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5'-bis-O-(tert-

butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 6, Chemical formula : C27H50N2O7S2Si2,
Observed mass [M-H]-: 633.2547 (Calculated mass = 633.2525).

Figure 3.11 1H NMR of S-(3(acetylthio)propyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)5-(mercaptomethyl)-uridine, 6
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Figure 3.12 13C NMR of S-(3(acetylthio)propyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5(mercaptomethyl)-uridine, 6

De-protection of compound 6 using TEA.3HF and HF was initially challenging, and we
had difficulty removing TBDMS group from 2’ and 5’ position of the ribo-nucleoside. To
overcome this problem, we tried another protecting group (triisopropylsilyl (TIPS) ethers) to
protect simultaneously 3’ and 5’ of 5-methyluridine at the first step. However the reaction didn’t
work after step two. Therefore, we decided to use TBDMS again, but remove it from compound
5 first and then introduce thioacetate to it to obtain compound 7. This strategy was also
challenging: having two triol compound to purify by column was time consuming and not very
efficient. Other than using TEA.3HF and HF to remove TBDMS, we used another fluoride
reagent and solvent system for de-protection. Pyridine.HF complex (70%) and EtOH was
employed for 3', 5'-bis-O-desilylation reaction. The reaction was successful. However, the yield
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was not great. At the end, we were able to remove protecting groups using triethylamine
trihydrofluoride (TEA.3HF) in vary dry THF and obtain a higher yield. The molecular formation
of compound 7 was confirmed by ESI-MS (high resolution) analysis (Figure 3.13) and then
characterized by NMR (Figures 3.14 and 3.15).
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Figure 3.13 ESI-MS analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine, 7
Chemical formula: C15H22N2O7S2, Observed mass [M-H]-: 405.0787 (Calculated mass =
405.0796).

Figure 3.14 1H NMR of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine,7
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Figure 3.15 13CNMR of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine,7
S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5'-triphosphate (AcSUTP, compound
9, Scheme 2.2) was synthesized from S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine
(compound 7 in Scheme 2.1) using a relatively new methodology22 developed in our lab. Our
earlier attempts to synthesize the 5’-triphosphate of the deoxy-nucleoside version by using DMF
or DMF/1,4-dioxane (1:1) mixture as the solvent systems was not successful. Only after
dissolving the nucleoside in DMF/toluene (3:1) mixture, formation of triphosphate was observed.
Our hypothesis is that toluene can interact with the bulky base, providing better stacking and
therefore, causing the 5’ hydroxyl group more available to afford cyclic phosphate intermediate
(compound 8, Scheme 2.2). This strategy was used for the ribo version as well. In order to obtain
better yield and cleaner reaction, several optimization such as changing reaction time and the
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equivalent of the reagents were tried. The best yield was observed when reaction time between
nucleoside and triphosphate was 2 h (second step in Scheme 2.2) and the equivalent of
tributylammonium pyrophosphate and 2-chloro-4H-1,3,2-benzodioxa-phosphorin-4-on to the
nucleoside was 3 and 1.5 respectively. Compound 9 was characterized using HR-MS and 1H, 13C
and 31P NMR analysis as shown in Figures 3.16 to 3.19.
Razieh_7UTP-42min-prg-dry-largepeak_Huang-ACCU_10152013_ESI-NEG_01 #136-147
T: FTMS - p ESI Full ms [100.00-1000.00]
157.1229
z=?
100
95

AV: 12

SB: 203 0.48-1.58 , 2.72-4.39

NL: 3.54E4

482.9592
z=1

250.8525
z=1

90

RT: 1.97-2.12

85
80
75

199.1696
z=?

-

70

[M-H]

Relative Abundance

65

644.9756
z=1

AcSUTP

60
55
283.2631
z=1

50
45
40
35
30

461.8694
z=?

25

504.9410
z=?
565.0096
z=?

20
321.9843 371.0643 430.5922
z=1
z=2
z=?
402.9934
z=2

15
10

532.9594
z=?
605.5825
z=?

5
0
100

200

300

400

500

600

660.9704
z=?
728.8489
z=?

700

824.8078
870.9631 934.9512 986.1840
z=?
z=?
z=?
z=?

800

900

1000

m/z

Figure 3.17 ESI-MS analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5’triphpsphate, 9, Chemical formula: C15H25N2O16P3S2, Observed mass [M-H]-: 644.9756
(Calculated mass = 644.9786).

AcSUTP

Figure 3.16 1H NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)uridine-5’-triphpsphate, 9.
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AcSUTP

Figure 3.18 13C NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)uridine-5’-triphpsphate, 9.

AcSUTP

Figure 3.19

31

P NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5’-

triphpsphate, 9.
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The acetate protecting group of the thiol functionality of compound 9 was removed in
presence of ammonia, yielding S-mercaptopropyl-5-(mercaptomethyl)-uridine-5'-triphosphate
(HSUTP, Compound 10, Scheme 2.2). Figures 3.20 to 3.23 represent HR-MS and NMR analysis
of compound 10.
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Figure 3.20 ESI-MS analysis of S-mercaptopropyl-5-(mercaptomethyl)-uridine-5’triphpsphate 10, Chemical formula: C13H22N2O15P3S2, Observed mass [M-H]-: 602.9653
(Calculated mass = 602.9680).

HSUTP

Figure 3.21 1H NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10
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HSUTP

Figure 3.22 13C NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10

HSUTP

Figure 3.23 31P NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10
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3.2

RP-HPLC purification and analysis
The crude compound 9 (AcSUTP) was purified and analyzed by reverse-phase high-

performance liquid chromatography (RP-HPLC). Several HPLC programs were tried to get the
best resolution. Only the program shown in Figure 3.24 afforded the best separation. Compound
9 (AcSUTP) eluted at 20.20 min under this condition. Compound 10 was purified by only
NaCl/EtOH precipitation and then analyzed on RP-HPLC at flow rate of 1.0 mL/min under 260
nm. The HPLC profile of the crude compound 9 is shown in Figure 3.22. The desired peak had
retention time of 20.20 min and it was stronger than other peaks, meaning the synthesis has been
efficient and clean. All native uridine 5’-triphosphate and the purified thiol modified ones were
analyzed on RP-HPLC (Figure 3.25). Since AcSUTP and HSUTP are structurally similar, the
difference on their retention time on the column was small but measurable. The retention time
difference was much smaller in the deoxy version. RP-HPLC analysis of the deoxy version is
showed in Figure 3.26.

Figure 3.24 RP-HPLC profile of crude compound 9, and the program used, (retention
time of the desired peak: 20.20 min)
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Figure 3.25 RP-HPLC analysis of UTP, AcSUTP and HSUTP
UTP: orange curve, retention time: 11.48 min; AcSUTP: blue curve, retention time:
24.86 min; HSUTP: green curve, retention time: 23.25; Co-injection of all: violet curve,
retention times: 11.48, 23.25 and 24.86

AcS

TTP

HS

TTP

Figure 3.26 RP-HPLC analysis of AcSTTP and HSTTP1 HSTTP (red curve, retention
time: 24.75 min); AcSTTP (blue curve, retention time: 24.96 min) and co-injection of
AcSTTP and HSTTP (black curve, retention times: 24.75 and 24.96 min, respectively).
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3.3

UV-VIS absorption properties
The maximum UV absorption of the native uridine 5’-tripohosphate was measure at ~262

nm. The modified uridine 5’-triphosphate (AcSUTP & HSUTP) showed maximum absorption at
~267 nm, which is slightly different from that of the native UTP. The UV absorption profiles of
AcSUTP and AcSUTP were similar (Figure 3.27). Unlike uridine, modification at the nucleobase
of thymidine did not change the wavelength of the maximum absorption of the native TTP at all.
All TTP, S-(3(acetylthio)propyl)-5-(mercaptomethyl)-2'-deoxyuridine-5'- triphosphate (AcSTTP)
and S-mercaptopropyl-5-(mercaptomethyl)-2'-deoxyuridine-5'- triphosphate, (HSTTP)
similar UV absorption profiles (Figure 3.28).

Figure 3.27 UV absorption spectra of UTP (—), AcSUTP (—), and HSUTP (—) in water at
room temperature.

have

34

Figure 3.28 UV absorption spectra of TTP (—), AcSTTP (—), and HSTTP (—) in water at room
temprature.1

3.4

Enzymatic studies
3.4.1

RNA in vitro transcription by T7 RNA polymerase

Transcription of the RNA for the native and the thiol-modified nucleotides were
performed using T7 RNA polymerase and by following the manufacturer procedure (Epicentre,
AmpliScribe T7- Flash Transcription Kit). A 55-mer DNA template and the complementary
promoter for the T7 RNA polymerase were used in presence of all NTPs and radioactive α-[32P]ATP. The transcribed RNA’s were analyzed on a 19% PAGE. Autoradiogram of the time-course
experiment of the transcription is shown in Figure 3.29. From the intensity of the bands, it can be
determined that the modified nucleotides are recognizable by T7 RNA polymerase and can act as
good substrates for the T7 enzyme. It was observed that transcription of AcSUTP substrate is
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initially faster but the yield is lower than that of native. The transcription yield of HSUTP seems
even better than the native UTP. Incorporation of the HSUTP & AcSUTP into RNA will be
further confirmed by MALDI-MS.

Figure 3.29 Transcription time course experiment. a) Sequences of promoter and template used
and the poduct of the reaction in presence of T7 RNA polymerase. b) Gel autoradiogram of
the reaction (analyzed on 19% PAGE). c) Normalized curves, quantified by phosphoroimager,
intensities were measure by reference to the intensity of UTP in 120 min as 100%.
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Transcription was also carried out using three other templates shown in Figure 3.30.
These templates were designed in such a way that the ribozyme thus produced will have C
instead of U in two positions. Therefore, in each sequence of these templates, one A has been
replaced by G. The reaction time was 2 h, and 19% PAGE was used for analysis. The results
showed that the modified nucleotides (AcSUTP & HSUTP) gave better yield compared to the
native UTP.

Figure 3.30 Transcription experiment using mutant templates; a) sequences of promoter and
templates used; b) sequences of the ribozymes thus produced; c) gel autoradiogram of the
experiment.
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3.4.2

Ribozyme catalytic activity analysis

The activity of the transcribed hammerhead ribozyme was examined by incubating the
5’-32P labeled 20-nt substrate with the transcribed RNAs in presence of Tris-HCl/MgCl2 buffer.
The gel image (Figure 3.31) shows that the 5′-radio labeled RNA substrate was cleaved into the
9-nt fragment and the 5′-32P-RNA fragment (11-nt), suggesting that the thiol-modified ribozymes
are as active as the native counterpart.

Figure 3.31 Catalytic activity of the modified ribozyme and the native counterpart.
a) Secondary structure of the transcribed hammerhead ribozyme and its labeled
substrate. The red letters indicated that the bases are highly conserved. b)
Normalized curves of the modified ribozymes activity (red and green curves) by
comparison to the cleavage of the substrate by the native U-ribozyme (120 min was
defined as 1). c) time-course experiment of the digestion of the labeled substrate at
5’-end by hammerhead native and modified ribozymes.
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3.4.3

Ribozyme durability study

To examine the durability of the transcribed ribozyme, they were 10 fold diluted with
respect to the concentrations in the activity study and were incubated with 5’-32p-labeled RNA
substrate at room temperature for longer time. The time intervals were 0, 2, 4, 6, 24 and 72 h.
The autoradiograph of this experiment (Figure 3.32) indicates that the AcSU-modified ribozymes
is as durable as the native one. However, HSU-ribozyme did not show durability like the native
one.

Figure 3.32 Gel autoradiogram of the ribozyme durability study

3.4.4

Nuclease resistance experiment

The stability of the transcribed ribozymes was examined by incubating the transcribed
RNAs with different nucleases including Fetal Bovine Serum (FBS), phosphodiesterase (PDE) I
from Crotalus Adamanteus venom and RNase R (various amounts and different reaction times)
and analyzed on 19% gel electrophoresis and autoradiography (Figures 3.33, 3.34, 3.35 and
3.36).
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Figure 3.33 PAGE autoradiography of nuclease resistance experiment.
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA,
enzyme concentration used: 0.1 U/μL of RNase R, 0.04% of Fetal Bovine Serum (FBS)
and 10-5 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37 °C for
30 min.

Figure 3.34 PAGE autoradiography of nuclease resistance experiment.
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA,
enzyme concentration used: 0.05 U/μL of RNase R, 0.02% of Fetal Bovine Serum (FBS)
and 10-5 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37 °C for
30 min.
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Figure 3.35 PAGE autoradiography of nuclease resistance experiment.
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA,
enzyme concentration used: 0.1 U/μL of RNase R, 0.006% of Fetal Bovine Serum (FBS)
and 0.3x10-5 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37
°C for 30 min.

Figure 3.36 PAGE autoradiography of nuclease resistance experiment.
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA,
enzyme concentration used: 0, 0.1, 0.01, 0.001 U/μL of RNase R. Reaction mixtures were
incubated at 37 °C for 1h.
The result shows that the modified RNAs are relatively resistant to the nucleases and
their stability is similar to the native.
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3.4.5

Incorporation of 2’-deoxy version of nucleotides into DNA1

The

incorporation

deoxyuridine-5'-triphosphate

efficiency

of

(AcSTTP,

9)

S-(3(acetylthio)propyl)-5-(mercaptomethyl)-2'and

S-mercaptopropyl-5-(mercaptomethyl)-2'-

deoxyuridine-5'-triphosphate, (HSTTP, 10) into DNA was investigated by using different
combination of DNA templates and primers (listed in Table 3.1) under Klenow exo-minus DNA
polymerase (Kf-).

Table 3.1 Sequences of the DNA primers and templates used for enzymatic incorporation of
TTP/HSTTP/AcSTTP into DNA. The highlighted bases are where incorporation of “T” occurs.
Primers:

P1 (17-mer) 5'-d-TAG CGG GTT GCT GGT GG -3'
P2 (21-mer) 5'-d-GCG TAA TAC GAC TCA CTA TAG-3'

Templates: T1 (21-mer) 3'-d-ATC GCC CAA CGA CCA CCA TGG- 5'
T2 (23-mer) 3'-d-ATC GCC CAA CGA CCA CCAAAT GG- 5'
T3 (55-mer) 3'-d-CGC ATT ATG CTG AGT GAT ATC CGT TGG ACT ACT
CCG GCT TTC CGG CTT TGC ATG T -5'
The DNA polymerization was carried out with primer (1.5 μM), template (3 μM), all
NTPs including TTP/AcSTTP/ HSTTP (0.1 mM each), and Klenow exo(-) DNA polymerase
(various concentrations) and analyzed by 19% polyacrylamide gel electrophoresis (Figures 3.37,
3.39 and 3.40).
The results showed that AcSTTP and HSTTP act as good substrates for DNA
polymerase, like TTP. A relatively short DNA template (T1, 21-nt) was used to study single
nucleotide incorporation. As can be seen in Figure 3.37, AcSTTP is a better substrate for DNA
polymerase: in different conditions (various enzyme concentration and reaction time), AcSTTP
terminates DNA polymerization once single nucleotide incorporates into DNA (n+1 DNA),
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while TTP and HSTTP cause formation of either n+1 DNA or a mixture of n+1 and n+2 DNA.
In addition, the intensity of the products on the gel autoradiogram indicates that DNA
polymerase can recognize both HSTTP and AcSTTP well. Moreover, it appears that there is a
measurable difference in the mobility of the products as a result of structural impact that
modification causes. The single nucleotide incorporation of HSTTP is confirmed by MALDI-MS
analysis (Figure 3.38). AcSTTP single nucleotide incorporation will be confirmed by MALDIMS as well.

Figure 3.37 Single nucleotide enzymatic incorporation of TTP/AcSTTP/HSTTP into DNA (T1):
(a) incorporation of TTP/AcSTTP/HSTTP by Klenow exo(-) into DNA template T1. PAGE
autoradiography of the polymerization reaction with (b) Kf(-) = 0.0015 U/µL and reaction time
= 60 min for TTP and 90 min for AcSTTP and HSTTP, (c) Kf(-) = 0.00075 U/µL and
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reaction time = 60 min, (d) Kf(-) = 0.0015 U/µL and reaction time = 30 min, and (d) Kf(-) =
0.00075 U/µL and reaction time = 30 min.

Figure 3.38 MALDI-TOF MS analysis of the single nucleotide incorporation of HSTTP into
DNA by Kf(-).Chemical Formula: C181H229N68O111P17S2, matrix: 3-hydroxypicolinicacid
(3HPA); Observed mass: 5722.6 (Cal. mass: 5720.9)

In order to examine the incorporation efficiency of three consecutive modified thymidine
5’-triphosphates, template T2 was used. Primer P1 (17-nt) was extended to a 20-nt DNA using
Kf(-) and by incorporation of three consecutive “T” bases on template T2. The DNA
polymerization reaction was carried out in the presence of (1.5 μM), template (3 μM), TTP/
AcSTTP/ HSTTP (0.1 mM), and Klenow exo(-) DNA polymerase (0.0015 U/µL) and then was
analyzed on a 19% PAGE (Figure 3.39). The incubation time for TTP was 5 min (Figure3.39,
lane 2) while AcSTTP and HSTTP were incubated for 60 min (Figure3.39, lanes 3 and 4,
respectively). In these conditions, AcSTTP seems to be the best substrate for DNA polymerase.
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We also designed a longer DNA template (55-nt, T3) to further investigate the
incorporation efficiency. The polymerization reaction was performed on extension of primer P2
(21-nt) over template T3 (55-nt). The reaction was carried out using primer (1.5 μM), template (5
μM), all dNTPs including TTP/ AcSTTP/TTP (0.1 mM), and Klenow exo(-) DNA polymerase
(0.04 U/μL) followed by analyzing on a 19% PAGE. The results are shown in Figure 3.40. Three
“T” were involved in this reaction

Figure

3.39

Enzymatic

incorporation

of

three

consecutive

thymidine

bases

(TTP/AcSTTP/HSTTP) into DNA (template T2):
(a) Polymerization reaction of TTP, AcSTTP and HSTTP by Klenow exo(-) over DNA template
T2. (b) Gel electrophoresis autoradiography of the incorporation reaction with Kf(-)= 0.0015
U/µL, incubation time = 5 min for TTP (lane 2) and 60 min for HSTTP (lane 3) and AcSTTP
(lane 4).
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Figure 3.40 a) DNA polymerization reaction in presence of all dNTPs including TTP, AcSTTP
and HSTTP using template T3 and Klenow exo(-) b) Gel electrophoresis autoradiography of the
experiment with Kf(-) = 0.0015 U/µL, incubation time = 60 min for TTP (lane 3) and 90 min
HSTTP (lane 4) and AcSTTP (lane 5).
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4

CONCLUSIONS AND FUTURE PROSPECTS

We have successfully synthesized and characterized a novel nucleoside, S-(3’-Sacetylpropyl)-5-(mercaptomethyl)-uridine, from 5-methyl uridine. The purified nucleoside was
used to synthesize S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine -5'-triphosphate and Smercaptopropyl-5-(mercaptomethyl)-uridine

-5'-triphosphate.

Both

triphosphates

were

characterized successfully. The triphosphates thus formed were used as a substrate for T7 RNA
polymerase. A 55-nt dsDNA templates and promoter were used to incorporate the modified
triphosphate into RNA. The experiments showed that the modified ribozymes transcribed are as
active as the native counterpart and this modification at the nucleobase will not cause any
deficiency in the catalytic activity of the ribozymes. Like the native RNA, the modified ones are
relatively resistant to the nucleases. The 2’-deoxy version of the same nucleoside and nucleotide
were also synthesized and characterized. It was observed that the 2’-doxy thiol-modified
nucleotide can act as an efficient substrate for DNA polymerase. The modified RNA/DNA thus
obtained will be used for gold nanoparticle stabilization. Since Au-nanoparticles have strong
affinity for thiol-functionality, the study will be based on that. The modified RNA/DNA will also
find use and application in DNA/RNA microchip surface functionalization for rapid detection of
disease and pathogens and also, it will be utilized in studying nucleic acid/protein complexes
structure and function.
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Appendix A: ESI HR-Mass spectra
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Appendix B: 1H NMR spectra
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Appendix C: 13C NMR spectra
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APENDIX D: 31P NMR spectra

